Cytomegalovirus prophylaxis in solid organ transplant recipients

被引:145
作者
Patel, R
Snydman, DR
Rubin, RH
Ho, M
Pescovitz, M
Martin, M
Paya, CV
机构
[1] MAYO CLIN,DIV INFECT DIS & INTERNAL MED,ROCHESTER,MN 55905
[2] TUFTS UNIV NEW ENGLAND MED CTR,BOSTON,MA 02111
[3] TUFTS UNIV,SCH MED,BOSTON,MA 02111
[4] MASSACHUSETTS GEN HOSP,TRANSPLANTAT UNIT,BOSTON,MA 02114
[5] MASSACHUSETTS GEN HOSP,INFECT DIS UNIT,BOSTON,MA 02114
[6] UNIV PITTSBURGH,GRAD SCH PUBL HLTH,PITTSBURGH,PA 15261
[7] INDIANA UNIV,MED CTR,DEPT SURG,TRANSPLANTAT SECT,INDIANAPOLIS,IN 46202
[8] UNIV IOWA HOSP & CLIN,DEPT TRANSPLANTAT,IOWA CITY,IA
关键词
D O I
10.1097/00007890-199605150-00001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1279 / 1289
页数:11
相关论文
共 58 条
[1]   PROSPECTIVE RANDOMIZED TRIAL OF EFFICACY OF GANCICLOVIR VERSUS THAT OF ANTICYTOMEGALOVIRUS (CMV) IMMUNOGLOBULIN TO PREVENT CMV DISEASE IN CMV-SEROPOSITIVE HEART-TRANSPLANT RECIPIENTS TREATED WITH OKT3 [J].
AGUADO, JM ;
GOMEZSANCHEZ, MA ;
LUMBRERAS, C ;
DELGADO, J ;
LIZASOAIN, M ;
OTERO, JR ;
RUFILANCHAS, JJ ;
NORIEGA, AR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1643-1645
[2]   CYTOMEGALOVIRUS-INFECTION PERSISTS IN THE LIVER GRAFT IN THE VANISHING BILE-DUCT SYNDROME [J].
ARNOLD, JC ;
PORTMANN, BC ;
OGRADY, JG ;
NAOUMOV, NV ;
ALEXANDER, GJM ;
WILLIAMS, R .
HEPATOLOGY, 1992, 16 (02) :285-292
[3]  
Bailey T C, 1993, Semin Respir Infect, V8, P225
[4]   FAILURE OF HIGH-DOSE ORAL ACYCLOVIR WITH OR WITHOUT IMMUNE GLOBULIN TO PREVENT PRIMARY CYTOMEGALOVIRUS DISEASE IN RECIPIENTS OF SOLID-ORGAN TRANSPLANTS [J].
BAILEY, TC ;
ETTINGER, NA ;
STORCH, GA ;
TRULOCK, EP ;
HANTO, DW ;
DUNAGAN, WC ;
JENDRISAK, MD ;
MCCULLOUGH, CS ;
KENZORA, JL ;
POWDERLY, WG .
AMERICAN JOURNAL OF MEDICINE, 1993, 95 (03) :273-278
[5]   A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ORAL ACYCLOVIR FOR THE PREVENTION OF CYTOMEGALO-VIRUS DISEASE IN RECIPIENTS OF RENAL-ALLOGRAFTS [J].
BALFOUR, HH ;
CHACE, BA ;
STAPLETON, JT ;
SIMMONS, RL ;
FRYD, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21) :1381-1387
[6]  
BALFOUR HH, 1985, TRANSPLANT P, V17, P81
[7]   HEPATITIS-C INFECTION IN PATIENTS WITH PRIMARY HYPOGAMMAGLOBULINEMIA AFTER TREATMENT WITH CONTAMINATED IMMUNE GLOBULIN [J].
BJORO, K ;
FROLAND, SS ;
YUN, ZB ;
SAMDAL, HH ;
HAALAND, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (24) :1607-1611
[8]  
BOIVIN G, 1993, J INFECT DIS, V168, P322
[9]   EVALUATION OF SQ-34,514 - PHARMACOKINETICS AND EFFICACY IN EXPERIMENTAL HERPESVIRUS INFECTIONS IN MICE [J].
BRAITMAN, A ;
SWERDEL, MR ;
OLSEN, SJ ;
TUOMARI, AV ;
LYNCH, JS ;
BLUE, B ;
MICHALIK, T ;
FIELD, AK ;
BONNER, DP ;
CLARK, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (07) :1464-1468
[10]   FORMULATION OF AN IMMUNOGENIC HUMAN CYTOMEGALOVIRUS VACCINE - RESPONSES IN MICE [J].
BRITT, W ;
FAY, J ;
SEALS, J ;
KENSIL, C .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :18-25